TD Private Client Wealth’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.24K | Buy |
820
+366
| +81% | +$4.13K | ﹤0.01% | 1059 |
|
|
2025
Q1 | $4.58K | Buy |
+454
| New | +$4.58K | ﹤0.01% | 1090 |
|
|
2024
Q4 | – | Sell |
-454
| Closed | -$5.24K | – | 1342 |
|
|
2024
Q3 | $5.24K | Hold |
454
| – | – | ﹤0.01% | 1111 |
|
|
2024
Q2 | $4.8K | Buy |
454
+76
| +20% | +$803 | ﹤0.01% | 1092 |
|
|
2024
Q1 | $3.98K | Sell |
378
-72
| -16% | -$759 | ﹤0.01% | 1101 |
|
|
2023
Q4 | $5.05K | Sell |
450
-191
| -30% | -$2.15K | ﹤0.01% | 1114 |
|
|
2023
Q3 | $7.49K | Sell |
641
-1,168
| -65% | -$13.6K | ﹤0.01% | 1071 |
|
|
2023
Q2 | $18.2K | Buy |
+1,809
| New | +$18.2K | ﹤0.01% | 961 |
|